ID
32378
Descripción
This ODM file contains the form for documentation of any concomitant medication. To be assessed at screening and re-assessed at every visit. Study ID: 103880 Clinical Study ID: ARI103880 Study Title: An open label, single dose, randomized, three period crossover study to investigate the relative bioavailability of 0.5 mg of dutasteride from soft gelatin capsules (reference) vs. soft gelatin capsules containing two investigational formulations in healthy male volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Duagen,Zytefor,Avolve,Avodart,Avidart,Zyfetor; Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Prostatic Hyperplasia
Palabras clave
Versiones (2)
- 28/10/18 28/10/18 -
- 28/10/18 28/10/18 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
28 de octubre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Dutasteride Relative Bioavailability Soft Gelatine Capsules ID 103880
Concomitant Medication
- StudyEvent: ODM
Descripción
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Descripción
MONITOR DATA VALIDATION CHECKS • Check that either ’Yes’ or ’No’ box at the top of the page has been completed. If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2347852
Descripción
List of Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Descripción
MONITOR DATA VALIDATION CHECKS Ensure that the spelling of the Drug Name(s) is correct (use of Trade Names is preferred).
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2360065
Descripción
Unit Dose of Medication
Tipo de datos
float
Alias
- UMLS CUI [1]
- C2826646
Descripción
INVESTIGATOR INSTRUCTIONS UNITS Abbreviation Label TAB = Tablet MCL = Microlitre ML = Millilitre L = Litre MCG = Microgram MG = Milligram G = Gram
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1519795
Descripción
INVESTIGATOR INSTRUCTIONS FREQUENCY Abbreviation Label OD/QD = 1 x Daily BID = 2 x Daily TID = 3 x Daily QID = 4 x Daily PRN = As required
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3476109
Descripción
INVESTIGATOR INSTRUCTIONS ROUTE Abbreviation Label IM = Intramuscular IH = Inhalation IV = Intravenous NS = Nasal TP = Topical PO = Oral VG = Vaginal
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
Reason for Medication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826696
Descripción
INVESTIGATOR INSTRUCTIONS • Record unknown months as UNK. MONITOR DATA VALIDATION CHECKS • Check that either medication start date is completed or ’Taken Prior to Study?’ is ’Yes’. • It is acceptable for start date to be missing if ’Taken Prior to Study?’ is ’Yes’. • It is acceptable if ’Taken Prior to Study?’ is ’Yes’ and a start date is present, as long as the start date is prior to the date of the subject’s initial visit.
Tipo de datos
partialDate
Alias
- UMLS CUI [1]
- C2826734
Descripción
Taken Prior to Study?
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826667
Descripción
MONITOR DATA VALIDATION CHECKS • Check that either medication stop date is completed or ’Ongoing Medication?’ is ’Yes’. • It is acceptable for stop date to be missing if ’Ongoing Medication?’ is ’Yes’.
Tipo de datos
partialDate
Alias
- UMLS CUI [1]
- C2826744
Descripción
Ongoing Medication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant Medication
- StudyEvent: ODM